Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.82 USD | -0.22% | +0.62% | +23.58% |
Apr. 09 | Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating | MT |
Apr. 08 | Shanghai Henlius Biotech Denosumab Biosimilar HLX14 Meets Endpoint | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.58% | 4.57B | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- OGN Stock
- News Organon & Co.
- Organon & Co Signs Global License Deal to Commercialize Breast Cancer Treatment Perjeta